Participatory Action Research to Evaluate the Delivery of the MISSION ABC Service Model and Assess Health Service and Clinical Outcomes

NCT03096509 | Completed DMC

• 1 other identifier: PHT/2016/84
• Study Type: observational
• Target: 342
• Locations: 1 country
• Sites: 1

Brief Summary

Innovations aimed at improving new patient identification, diagnosis, nonpharmacological treatment, supported self-management, and remote monitoring, together with new methods of clinical support could improve outcomes in patients with respiratory disease. The Investigators have developed a model of care incorporating key innovations for patients with asthma, COPD and undifferentiated breathlessness. This service is being implemented within Wessex CCGs. The investigators will assess whether the implementation of the service is effective, and how it can be adjusted, in addition to introducing innovations to assess whether the expected benefits for patients are realised.

Conditions

COPD; Asthma; Breathlessness

Outcome Measures

Primary Outcomes (1)

• Acceptability of clinic process measured through the collection of qualitative feedback.

  Qualitative feedback forms collected at ever clinical encounter, qualitative interviews at 3 months post clinic and HCP focus groups will generate qualitative data. This will be evaluated cyclically to inform changes in the clinic structure.

  up to 18 months

Secondary Outcomes (15)

• Number of changes in primary diagnosis or classification of disease severity resulting from a MISSION clinic appointment.

  18 months

• Number of additional co-morbid medical conditions identified from a MISSION clinical encounter.

  18 months

• Frequency of uptake and attendance at the enhanced asthma education programme ESMENA

  18 months

• Changes in patients' perceived confidence in self-management before and after MISSION clinics and education sessions measured through questionnaire feedback

  18 months

• Uptake and acceptability of HCP education through the MISSION process

  18 months

Interventions

MISSION ABC Integrated Care clinic OTHER

The Investigators have developed a model of care incorporating key innovations for patients with asthma, COPD and undifferentiated breathlessness. This service is being implemented within Wessex CCGs.

Eligibility Criteria

• Age: 16 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17), Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

All patients invited to a MISSION ABC clinic, all Healthcare Professionals attending.

You may qualify if:

• Attendance at a MISSION ABC clinic or training session as a patient, carer or Healthcare Professional

You may not qualify if:

• Unable to give informed consent

Sponsors & Collaborators

• Portsmouth Hospitals NHS Trust: lead
• Wessex Academic Health Science Network: collaborator
• East Hampshire Better Local Care Fund: collaborator
• Pfizer: collaborator
• The Health Foundation: collaborator

Study Sites (1)

Portsmouth Hospitals NHS Trust

Portsmouth, PO6 3LY, United Kingdom

Location

Related Publications (2)

• Heiden E, Longstaff J, Chauhan MJA, DeVos R, Lanning E, Neville D, Jones TL, Begum S, Amos M, Mottershaw M, Micklam J, Holdsworth B, Rupani H, Brown T, Chauhan AJ; Mission ABC Collaborators. MISSION ABC: transforming respiratory care through one-stop multidisciplinary clinics - an observational study. BMJ Open. 2024 Jan 8;14(1):e078947. doi: 10.1136/bmjopen-2023-078947.

  PMID: 38191248 DERIVED

• Fox L, Heiden E, Chauhan MAJ, Longstaff JM, Balls L, De Vos R, Neville DM, Jones TL, Leung AW, Morrison L, Rupani H, Brown TP, Stores R, Chauhan AJ. Evaluation of telehealth support in an integrated respiratory clinic. NPJ Prim Care Respir Med. 2022 Nov 11;32(1):51. doi: 10.1038/s41533-022-00304-9.

  PMID: 36369507 DERIVED

MeSH Terms

Conditions

Pulmonary Disease, Chronic Obstructive; Asthma; Dyspnea

Condition Hierarchy (Ancestors)

Lung Diseases, Obstructive; Lung Diseases; Respiratory Tract Diseases; Chronic Disease; Disease Attributes; Pathologic Processes; Pathological Conditions, Signs and Symptoms; Bronchial Diseases; Respiratory Hypersensitivity; Hypersensitivity, Immediate; Hypersensitivity; Immune System Diseases; Respiration Disorders; Signs and Symptoms, Respiratory; Signs and Symptoms

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER GOV
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: March 1, 2017
• First Posted: March 30, 2017
• Study Start: January 19, 2017
• Primary Completion: March 31, 2018
• Study Completion: March 31, 2018
• Last Updated: April 7, 2023

Record last verified: 2023-04

Locations

GB (1)